TP53 and cancer: Our CRC xenograft model studies indicate that the role of LVBU in promoting cell proliferation, causing deregulation of p53-mediated urea cycle, and facilitating polyamine biosynthesis can be recapitulated in vivo, and that DFMO’s treatment efficacy in suppressing cancer can be explored further in CRC.